Previous close | 1.4800 |
Open | 1.4665 |
Bid | 1.4100 x 100 |
Ask | 1.5100 x 100 |
Day's range | 1.4254 - 1.5300 |
52-week range | 1.2100 - 7.9700 |
Volume | |
Avg. volume | 158,971 |
Market cap | 50.234M |
Beta (5Y monthly) | 1.12 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.5400 |
Earnings date | 09 May 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 3.63 |
CLEARWATER, Fla., April 25, 2024--Apyx Medical Corporation (NASDAQ:APYX) (the "Company"), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion®, today announced that financial results for the first quarter of fiscal year 2024 will be released before the market opens on Thursday, May 9th.
CLEARWATER, Fla., April 11, 2024--Apyx® Medical Corporation (NASDAQ:APYX) (the "Apyx Medical"; "Company"), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion®, is pleased to announce the Renuvion Users’ Summit is taking place in Las Vegas from April 12-13, 2024.
One thing we could say about the analysts on Apyx Medical Corporation ( NASDAQ:APYX ) - they aren't optimistic, having...